|
|
Assessing mobility in multiple sclerosis using the Rivermead Mobility Index and gait speed
C. Vaney
Neurologische Rehabilitations-und MS-Abteilung, Berner Klinik Montana, Switzerland
H. Blaurock
Neurologische Rehabilitations-und MS-Abteilung, Berner Klinik Montana, Switzerland
B. Gattlen
Neurologische Rehabilitations-und MS-Abteilung, Berner Klinik Montana, Switzerland
C. Meisels
Neurologische Rehabilitations-und MS-Abteilung, Berner Klinik Montana, Switzerland
Measurement tools assessing disability in MS patients are essential to evaluate the effect of the growing number of drug treatments and to measure rehabilitation outcome. However, the most widely used EDSS (Expanded Disability Status Scale) has been shown to be insensitive to minor changes. The assessment of disability with simple measures such as the Rivermead Mobility Index (RMI) and gait speed timed over 10 m has been suggested. Two hundred MS patients attending a rehabilitation centre were assessed at the beginning and at the end of a four-week period (median 28.2 days; interquartile range (IQR) 1.8 days) using these two measures as well as the EDSS and the Ambulation Index (AI). The RMI was the most sensitive scale and measured changes in 39% of the patients, whereas AI changed in 18.5% and EDSS in only 7.5% of the patients. The RMI assessed more precisely ambulatory patients needing walking aids, for which EDSS proposes only two options (EDSS 6.0/6.5). To measure the variability of the 10 m walking time, 25 of the 115 ambulant patients were asked to cover the distance at five different times on the same day chosen at random. Variability within one patient on test-retest was calculated by dividing the standard deviation of the five measures by the mean value of the measures. In spite of its great variability of 20 ± 8%, gait speed timed over 10 m was as sensitive as the AI and measured changes in 16.5% of these ambulatory patients (AI in 15.6%). The RMI and gait speed timed over 10 m should be used more widely to assess disability and to measure the physiotherapeutic effort devoted to improving mobility of MS patients.
Clinical Rehabilitation, Vol. 10, No. 3,
216-226 (1996)
DOI: 10.1177/026921559601000306
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
C. Barrett, G. Mann, P. Taylor, and P Strike
A randomized trial to investigate the effects of functional electrical stimulation and therapeutic exercise on walking performance for people with multiple sclerosis
Multiple Sclerosis,
April 1, 2009;
15(4):
493 - 504.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M A Newman, H Dawes, M van den Berg, D T Wade, J Burridge, and H Izadi
Can aerobic treadmill training reduce the effort of walking and fatigue in people with multiple sclerosis: a pilot study
Multiple Sclerosis,
January 1, 2007;
13(1):
113 - 119.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S J Crenshaw, T D Royer, J G Richards, and D J Hudson
Gait variability in people with multiple sclerosis
Multiple Sclerosis,
September 1, 2006;
12(5):
613 - 619.
[Abstract]
[PDF]
|
|
|
|
|
|
|
C. Sackley, P. Richardson, K. McDonnell, S. Ratib, M. Dewey, and H. J Hill
The reliability of balance, mobility and self-care measures in a population of adults with a learning disability known to a physiotherapy service
Clinical Rehabilitation,
February 1, 2005;
19(2):
216 - 223.
[Abstract]
[PDF]
|
|
|
|
|
|
|
O.R. Pearson, M.E. Busse, R.W.M. van Deursen, and C.M. Wiles
Quantification of walking mobility in neurological disorders
QJM,
August 1, 2004;
97(8):
463 - 475.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C Vaney, M Heinzel-Gutenbrunner, P Jobin, F Tschopp, B Gattlen, U Hagen, M Schnelle, and M Reif
Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study
Multiple Sclerosis,
August 1, 2004;
10(4):
417 - 424.
[Abstract]
[PDF]
|
|
|
|
|
|
|
C Vaney, S Vaney, and D T Wade
SaGA S, the Short and Graphic A bility Score: an alternative scoring method for the motor components of the Multiple Sclerosis Functional C omposite
Multiple Sclerosis,
April 1, 2004;
10(2):
231 - 242.
[Abstract]
[PDF]
|
|
|
|
|
|
|
F. Franchignoni, L. Tesio, E. Benevoloand, and M. Ottonello
Psychometric properties of the Rivermead Mobility Index in Italian stroke rehabilitation inpatients
Clinical Rehabilitation,
March 1, 2003;
17(3):
273 - 282.
[Abstract]
[PDF]
|
|
|
|
|
|
|
P. Rossier and D. T Wade
The Guy's Neurological Disability Scale in patients with multiple sclerosis: a clinical evaluation of its reliability and validity
Clinical Rehabilitation,
January 1, 2002;
16(1):
75 - 95.
[Abstract]
[PDF]
|
|
|
|
|
|
|
H Albrecht, C Wotzel, L P Erasmus, M Kleinpeter, N Konig, and W Pollmann
Day-to-day variability of maximum walking distance in MS patients can mislead to relevant changes in the Expanded Disability Status Scale (EDSS): average walking speed is a more constant parameter
Multiple Sclerosis,
April 1, 2001;
7(2):
105 - 109.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. A Forlander and R. W Bohannon
Rivermead Mobility Index: a brief review of research to date
Clinical Rehabilitation,
February 1, 1999;
13(2):
97 - 100.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S E Lord, D T Wade, and P W Halligan
A comparison of two physiotherapy treatment approaches to improve walking in multiple sclerosis: a pilot randomized controlled study
Clinical Rehabilitation,
June 1, 1998;
12(6):
477 - 486.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S E Lord, P W Halligan, and D T Wade
Visual gait analysis: the development of a clinical assessment and scale
Clinical Rehabilitation,
February 1, 1998;
12(2):
107 - 119.
[Abstract]
[PDF]
|
|
|
|
|
